|Bid||1.7200 x 925800|
|Ask||1.7500 x 411200|
|Day's range||1.6850 - 1.7500|
|52-week range||0.8000 - 2.6800|
|Beta (5Y monthly)||-0.04|
|PE ratio (TTM)||23.97|
|Earnings date||23 Aug 2022 - 29 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||2.75|
The big shareholder groups in Cogstate Limited ( ASX:CGS ) have power over the company. Large companies usually have...
Clario, a technology company that delivers the leading endpoint solutions for decentralized (DCT), hybrid and site-based clinical trials, announced today, on World Clinical Trials Day, an expansion of its partnership with cognitive science company, Cogstate, to jointly provide data quality solutions to support the unique requirements of neuroscience assessments for therapeutic development.
Cogstate (ASX:CGS) has had a great run on the share market with its stock up by a significant 17% over the last three...